EUDRAVIGILANCE at 1228780 VAERS at 700065, Bromelain, Sea Lettuce,  prostacyclin, mAbs, FOIA + DATA
Channel: VHFILM
Date: 2021-12-05

0:00 Open with the FDA Defense Quote " After the December 1 production, FDA proposes to work through the list of documents that Plaintiff requested FDA prioritize for production in order of priority and process and release the non-exempt portions of those records to Plaintiff on a rolling basis. FDA proposes to process and produce the non-exempt portions of responsive records at a rate of 500 pages per month. This rate is consistent with processing schedules entered by courts across the country in FOIA cases" . ***Meaning the Vaccine Data used for Approval will not be fully released until 2076 -  Hence professors and scientists from universities including Yale, Harvard, UCLA Brown, and many others from around the globe, filed suit in September in U.S. District Court for the Northern District of Texas, seeking expedited access to the records.
05:58 Quick look at Unusual findings from autopsies of vaccines over unvaccinated.
08:36 Quick look Immune imprinting’ by different SARS-CoV-2 spike sequences from variants and vaccines.
10:20 Quick Look of the incredibly rapid spread of Omicron, yet the incredibly low mortality rate, especially in low vaccinated nations such as South Africa.
16:00 Bromelain Quote" found that bromelain used alone and in combination with acetylcysteine can disrupt the integrity of spike and envelope proteins of the SARS-CoV-2 virus ( Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz )
22:46 Sea Lettuce  Quote "The US researchers built a cellular model to test the activity of the substance produced in Prof. Golberg's laboratory. The cells were exposed to both the Corona virus and also to ulvan (SEA LETTUCE). It was found that, in the presence of ulvan, the Corona virus does infect the cells." (TEL-AVIV UNIVERSITY).
26:41 Prostacyclin Quote" Furthermore, mortality was halved from 44% for the control group to 22% for the group receiving prostacyclin" ( UNIVERSITY OF COPENHAGEN - THE FACULTY OF HEALTH AND MEDICAL SCIENCES )
28:20 mAB 3B8 Quote: "In conclusion, the high therapeutic potency of mAb 3B8 in vivo against SARS-CoV-2 delta, achieved both as protein and encoded in plasmid, combined with its broad cross-reactivity against all other tested SARS-CoV-2 variants, make 3B8 a very interesting candidate to help fight the COVID-19 pandemic." ( KU Leuven, PharmAbs: the KU Leuven Antibody Center)
31:35 SARS-CoV-2-specific T cells in unexposed adults, Actually they existed prior to the pandemic ( Department of Medicine, Division of Rheumatology, Perelman School of Medicine, Institute for Immunology)
35:34 COVID-19 during pregnancy doesn’t harm baby’s brain ( RADIOLOGICAL SOCIETY OF NORTH AMERICA )
36:22 Immune Imprinting Quote "  yet the actual levels of protective neutralizing antibody responses against Delta had fallen to zero five months after their second dose. " ( IMPERIAL COLLEGE LONDON )
40:33 Boosters at best 50.8% effective against hospitalization ( US Department of Veterans Affairs )
42:53 High viral loads: what drives fatal cases of COVID-19 in vaccinees? an autopsy study
46:37 Wait what? FDA wants 55 years to process FOIA request over vaccine data (Reuters) 
01:03:43 Onward to Data


#bromelain #sealettuce #preexisting

Beneficial Properties of Bromelain
https://www.mdpi.com/2072-6643/13/12/4313/htm#B79-nutrients-13-04313
A natural substance extracted from marine algae prevents infection of cells with the Corona virus
https://www.eurekalert.org/news-releases/936182
Well-known drug could help the most severely affected Covid-19 patients in intensive-care departments
https://www.eurekalert.org/news-releases/936099
Potent neutralizing anti-SARS-CoV-2 human antibodies c**e infection with SARS-CoV-2 variants in hamster model
https://www.biorxiv.org/content/10.1101/2021.11.25.470011v1.full
SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens
https://www.biorxiv.org/content/10.1101/2021.11.29.470421v1.full
COVID-19 during pregnancy doesn’t harm baby’s brain
https://www.eurekalert.org/news-releases/935769
‘Immune imprinting’ by different SARS-CoV-2 spike sequences from variants and vaccines means we now have diverse patterns of protection against new variants
https://www.eurekalert.org/news-releases/936762
Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study
https://www.medrxiv.org/content/10.1101/2021.11.29.21266777v1
High viral loads: what drives fatal cases of COVID-19 in vaccinees? an autopsy study
https://www.medrxiv.org/content/10.1101/2021.12.03.21267155v1
COVID-19 mobile robot could detect and tackle social distancing breaches
https://www.eurekalert.org/news-releases/935940
Wait what? FDA wants 55 years to process FOIA request over vaccine data
https://www.reuters.com/legal/government/wait-what-fda-wants-55-years-process-foia-request-over-vaccine-data-2021-11-18/